<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<key-projects><projects><title>Characterization of Biologically Derived Drug Products</title><description>This project will develop and evaluate analytical methods to assess physicochemical attributes of biologically derived drug products that affect function.</description>
<dictionary></dictionary><outcome></outcome><accomplishment></accomplishment><table><title></title><overall-status><briefing>ON TRACK</briefing><prior-briefing>ON TRACK</prior-briefing></overall-status><row><type></type><milestone-description>1. Identify methods that characterize molecular structure (primary, secondary, tertiary), post translational modification and stability (aggregation/degradation)</milestone-description><milestone-date>6/30/2011</milestone-date><milestone-status>Completed</milestone-status><milestone-completion-date>6/30/2011</milestone-completion-date></row>
<row><type></type><milestone-description>2. Select model systems representing drug classes to assess suitability of methods</milestone-description><milestone-date>12/31/2011</milestone-date><milestone-status>Completed</milestone-status><milestone-completion-date>12/31/2011</milestone-completion-date></row>
<row><type></type><milestone-description>3. Establish analytical method capabilities to measure potential critical product quality attributes</milestone-description><milestone-date>9/30/2013</milestone-date><milestone-status>On Track</milestone-status><milestone-completion-date></milestone-completion-date></row>
<row><type></type><milestone-description>4.  Determine physicochemical comparability (define sameness)</milestone-description><milestone-date>9/30/2013</milestone-date><milestone-status>On Track</milestone-status><milestone-completion-date></milestone-completion-date></row>
<row><type></type><milestone-description>5. Document benefits and limitations of methods and develop publications</milestone-description><milestone-date>12/31/2013</milestone-date><milestone-status>On Track</milestone-status><milestone-completion-date></milestone-completion-date></row>
<footnotes><note></note></footnotes></table></projects><related-links><link><url>http://www.fda.gov/AboutFDA/Transparency/track/ucm206444.htm</url><text>FDA-TRACK CDER Dashboard</text></link></related-links></key-projects>
    






